A detailed history of Ci Private Wealth, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Ci Private Wealth, LLC holds 40,480 shares of ALKS stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,480
Previous 40,435 0.11%
Holding current value
$1.2 Million
Previous $974,000 16.32%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$23.01 - $28.55 $1,035 - $1,284
45 Added 0.11%
40,480 $1.13 Million
Q2 2024

Aug 13, 2024

BUY
$23.21 - $27.24 $410,097 - $481,303
17,669 Added 77.61%
40,435 $974,000
Q1 2024

May 09, 2024

BUY
$26.4 - $32.56 $354,288 - $436,955
13,420 Added 143.59%
22,766 $616,000
Q4 2023

Feb 09, 2024

BUY
$23.37 - $28.68 $218,416 - $268,043
9,346 New
9,346 $259,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.85B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Ci Private Wealth, LLC Portfolio

Follow Ci Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.